Grünenthal takes full ownership of Grünenthal Meds, the joint venture established with Kyowa Kirin for its established medicines brands

Grunenthal Group Germany United Kingdom United States of America

Grünenthal acquired Kyowa Kirin International's 49% stake in 'Grünenthal Meds', a joint venture formed in 2023 to market the established medicines portfolio from Kyowa Kirin International.Through this acquisition, Grünenthal assumes the sole responsibility of a portfolio comprising 12 brands across six therapeutic areas and >60 markets.& Instagram

For further information, please contact:
Maren Thurow, Head Global Communications at Grünenthal
[e-mail] 

View original content:https://www.prnewswire.co.uk/news-releases/grunenthal-takes-full-ownership-of-grunenthal-meds-the-joint-venture-established-with-kyowa-kirin-for-its-established-medicines-brands-302700929.html